CN110734398A - process for preparing 2-chloronicotinic acid - Google Patents

process for preparing 2-chloronicotinic acid Download PDF

Info

Publication number
CN110734398A
CN110734398A CN201810804247.7A CN201810804247A CN110734398A CN 110734398 A CN110734398 A CN 110734398A CN 201810804247 A CN201810804247 A CN 201810804247A CN 110734398 A CN110734398 A CN 110734398A
Authority
CN
China
Prior art keywords
acid
cyanopyridine
reaction
phosphorus oxychloride
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810804247.7A
Other languages
Chinese (zh)
Other versions
CN110734398B (en
Inventor
潘庆华
周卫国
吴波
冯利
江雪峰
韩朋
王金根
钱广
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU HANKUO BIOLOGICAL Co Ltd
Original Assignee
JIANGSU HANKUO BIOLOGICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU HANKUO BIOLOGICAL Co Ltd filed Critical JIANGSU HANKUO BIOLOGICAL Co Ltd
Priority to CN201810804247.7A priority Critical patent/CN110734398B/en
Publication of CN110734398A publication Critical patent/CN110734398A/en
Application granted granted Critical
Publication of CN110734398B publication Critical patent/CN110734398B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/803Processes of preparation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

The invention provides a preparation method of 2-chloronicotinic acids, which comprises the following steps of 1) reacting malonaldehyde with cyanoacetamide in the presence of acid to obtain a product containing 2-hydroxy-3-cyanopyridine, 2) reacting the product obtained in the step 1) with phosphorus oxychloride in the presence of alkali to generate 2-chloro-3-cyanopyridine, and 3) hydrolyzing the 2-chloro-3-cyanopyridine obtained in the step 2) to obtain the 2-chloronicotinic acid.

Description

process for preparing 2-chloronicotinic acid
Technical Field
The invention relates to the technical field of preparation of 2-chloronicotinic acid, in particular to a preparation method of novel 2-chloronicotinic acid.
Background
The 2-chloronicotinic acid is important pesticides and medical intermediates, is a key intermediate for synthesizing important medicaments such as efficient herbicides of nicosulfuron, diflufenican, nevirapine, mirtazapine and the like, and has important production value.
1. Chlorination of nicotinic acid
Figure BDA0001737815070000011
Although the process is simple, the method has the defects of high raw material price and poor product quality, and is difficult to meet the requirement of 2-chloronicotinic acid of medical grade (Said A, Brig W. pure white 2-chloronicotinic acid [ P ]. DE 2713316,1977-10-06).
2. Ethyl cyanoacetate-michael addition process
CNCH2COOC2H5+Cl2→CNCCl2COOC2H5+CNCH2COOC2H5
Figure BDA0001737815070000012
The process has the advantages of longer route, more types of used solvents, higher recovery difficulty and hidden danger in the aspect of environmental protection, and in addition, the used acrolein has higher toxicity and is easy to volatilize, which brings fixed difficulty to the production operation, so the process is not suitable for industrial production (Mayer Joseph. process for preparation 2-halogenic acidic acids [ P ]. USP 4081451,1978-03-28.).
3. 3-cyanopyridine chlorination process
Figure BDA0001737815070000021
However, the route has obvious defects of large three-waste emission amount, difficult treatment of a large amount of acid water and low yield (YukiGosei Kogyo Co. Ltd. Japan.2-chloronicotic acid [ P ]. JP 59144759,1984-08-18, Koei Kagaku Kogyo K, Japan.2-choro-3-cyanoxidine and 2-chloronicotic [ P ]. JP 56169672,1981-12-26.).
4. 2-chloro-3-methylpyridine oxidation process
The route has the advantages of simplicity, high yield and the like. However, the raw material 2-Chloro-3-methylpyridine is not produced in large quantities at present in China, so that the application of the route to large-scale production is not practical (Nie wenna, research on synthesis process of 2-chloronicotinic acid [ J ]. Hebei chemical industry, 2006,29(10):14-15, Ferre Gerardo, Cano Mondejar Juan C (Lisac S A, Spain).2-Chloro-3-pyridinecarboxylic acid [ P ]. ES 501988,1982-04-01).
In conclusion, the production of the 2-chloronicotinic acid has few routes which can be produced on a large scale at present and has problems, so that the development of new 2-chloronicotinic acid processes with industrial production value has very important social and economic values.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides novel preparation methods of 2-chloronicotinic acid, which have the advantages of short process route, high yield, less discharge of waste water and other three wastes and the like, and are suitable for large-scale production.
In order to achieve the purpose, the invention adopts the following technical scheme:
A preparation method of 2-chloronicotinic acid, which comprises the following steps:
1) reacting malondialdehyde with cyanoacetamide in the presence of acid to obtain a product containing 2-hydroxy-3-cyanopyridine;
2) reacting the product obtained in the step 1) with phosphorus oxychloride in the presence of alkali to generate 2-chloro-3-cyanopyridine;
3) hydrolyzing the 2-chloro-3-cyanopyridine obtained in the step 2) to obtain the 2-chloronicotinic acid.
The process route of the invention is as follows:
Figure BDA0001737815070000031
the raw material malondialdehyde used in the present invention may be malondialdehyde with or without crystal water.
Preferred embodiments are those wherein the molar ratio of malondialdehyde, cyanoacetamide, and acid in step 1) is from 1:1 to 1.2:0.1 to 0.5.
According to the preparation method, or more acids in organic acids or inorganic acids are adopted as the acid in the step 1), preferably, the acid can be but is not limited to organic acids such as acetic acid and propionic acid, also can be but is not limited to inorganic acids such as hydrochloric acid and sulfuric acid, and more preferably, the base in the step 2) can be but is not limited to triethylamine, pyridine, cyclohexylamine and the like.
In the preparation method of the invention, the reaction in the step 1) is carried out in the presence of a solvent, wherein the solvent is preferably or more of dichloromethane, ethyl acetate and chloroform, and more preferably dichloromethane.
In preferable embodiments of the preparation method, step 1) further comprises the steps of separating an organic phase from the product containing the 2-hydroxy-3-cyanopyridine obtained by the reaction in step 1), adding a saturated aqueous solution of sodium carbonate into the product containing the 2-hydroxy-3-cyanopyridine in specific embodiments, stirring, layering to separate an aqueous phase and an organic phase, separating the organic phase, drying the organic phase with anhydrous sodium sulfate, filtering to obtain a filtrate, and directly feeding the filtrate into step 2) as a raw material for the reaction with the phosphorus oxychloride, wherein in step 2), the molar ratio of the 2-hydroxy-3-cyanopyridine to the phosphorus oxychloride to the alkali is preferably 0.8:0.9-3.0: 0.7-1.5.
According to another preferred embodiments of the preparation method of the invention, step 1) further comprises the steps of separating an organic phase from the product containing 2-hydroxy-3-cyanopyridine obtained by the reaction in step 1), drying the organic phase with anhydrous sodium sulfate, filtering to obtain a filtrate, distilling off a solvent in the filtrate, and putting the filtrate into step 2) to react with phosphorus oxychloride, wherein in the scheme, phosphorus oxychloride serves as both the solvent and the reactant, and excess phosphorus oxychloride is preferably added during the reaction, and preferably, in step 2), the molar ratio of phosphorus oxychloride to alkali is 1: 0.8-1.2.
According to the preparation method of the invention, in specific embodiments, in step 3), the product obtained in step 2) is hydrolyzed under reflux in an aqueous solution of sodium hydroxide.
According to the preparation method provided by the invention, preferably, in the step 1), after dissolving malonaldehyde and cyanoacetamide in a solvent, the acid is dripped into a reaction system, the temperature of the reaction system is controlled to be not more than 15 ℃ in the acid dripping process, after the acid dripping is finished, the temperature is raised to the reflux of the system for reaction, and in specific embodiments of , the reaction time can be 5-6 hours.
Preferably, in the step 2), the alkali is dropwise added into a reaction system containing the product obtained in the step 1) and phosphorus oxychloride, the temperature of the reaction system is controlled to be 0-5 ℃, and after the alkali is dropwise added, the temperature is raised until the system is refluxed for reaction.
The technical scheme provided by the invention has the following beneficial effects:
the preparation method of the invention can overcome the defects of low yield, large discharge of three wastes, high treatment difficulty, large operation difficulty and the like in the prior art for producing the 2-chloronicotinic acid. The method takes malonaldehyde and cyanoacetamide as raw materials, and prepares the 2-chloronicotinic acid by cyclization and hydrolysis, has short route and higher yield, can avoid the generation of pyridine nitrogen oxide with potential safety hazard, greatly reduces waste water and other three wastes, has high product quality, and is particularly suitable for large-scale production.
Detailed Description
In order to better understand the technical solution of the present invention, the following example is further used to illustrate the content of the present invention, but the content of the present invention is not limited to the following example.
The starting materials used in the following examples are all commercially available in chemically pure form. The following description refers to instruments that may be involved, where the nuclear magnetism is: varian 400 MR; the mass spectrum is as follows: agilent 5975E; a micro melting point apparatus RT 3-03C; GC: agilent 7890A; liquid phase HPLC: agilent 1260.
Example 1
108g (1.0mol) of malondialdehyde (containing two water of crystallization) and 92.5g (1.1mol) of cyanoacetamide were charged into a 1000ml reaction flask, and 300ml of CH was added2Cl2Stirring and dissolving; after the system was cleared, 12g (0.2mol) of acetic acid was added dropwise thereto, and the addition was appropriately cooled so that the system temperature did not exceed 15 ℃. After the dropwise addition, slowly heating to the system for reflux, reacting for 5.5 hours, cooling the system to room temperature after the reaction is finished, adding 400ml of saturated sodium carbonate aqueous solution, stirring for half an hour, separating out a water layer, and discarding. The organic phase was dried over anhydrous sodium sulfate and filtered.
The filtrate obtained by filtration was subjected to atmospheric pressure and then to vacuum distillation to remove the solvent, thereby obtaining 106g of a pale yellow solid (a product containing 2-hydroxy-3-cyanopyridine), the HPLC purity was 96% and the yield was 88%.
Example 2
The product obtained in example 1 (containing 2-hydroxy-3-cyanopyridine, 0.88mol) was added to 250ml of POCl3(about 2.7mol) and stirring to dissolve the triethylamine, cooling the system to 0 ℃, slowly dropwise adding 101g (1.0mol) of triethylamine, controlling the temperature of the system to be between 0 and 5 ℃, and continuously stirring for half an hour at the temperature after dropwise adding; then, the temperature is slowly increased until the system is refluxed, and the reflux is maintained for 8 hours to finish the reaction. Recovering excess phosphorus oxychloride (POCl) under reduced pressure3) The system was added to 200ml of ice water, and the pH was adjusted to 11 with a small amount of NaOH to precipitate 117g of a brown precipitate (product containing 2-chloro-3-cyanopyridine), with a yield of 96.6%. The triethylamine in the mother liquor can be distilled and recovered.
Example 3
The product containing 2-hydroxy-3-cyanopyridine was prepared according to the method of example 1 except that the organic phase was dried over anhydrous sodium sulfate and filtered, the filtrate (containing 0.88mol of 2-hydroxy-3-cyanopyridine) was directly charged into the reaction, 153g (1.0mol) of phosphorus oxychloride was added to the solution, the temperature was reduced to 0-5 ℃ and 101g (1.0mol) of triethylamine was slowly added dropwise while maintaining the temperature, after the addition was completed, the temperature was raised to reflux the system, the reaction was carried out for 18 hours, 200ml of ice water was added to the system after the reaction was completed, the pH was adjusted to 11 with NaOH, the organic layer was separated, the aqueous layer was extracted times with 150ml of dichloromethane, the organic layer was combined, dried over anhydrous sodium sulfate, filtered, and the mother liquor was distilled under atmospheric pressure to recover the solvent, yielding 112g of a light brown solid (product containing 2-chloro-3-cyanopyridine), with a yield of 92..
Example 4
69g of the product obtained in example 2 (or example 3) (2-chloro-3-cyanopyridine, 0.5mol) was added to 300ml of water, 25g of sodium hydroxide was added, the mixture was heated under reflux for hydrolysis for 3 hours, then 3.0g of activated carbon was added and stirring was continued for 0.5 hour, hot filtration was carried out, the filtrate was cooled to room temperature, pH was adjusted to 5 with concentrated hydrochloric acid, and the cake was filtered and washed with water to obtain 71g of 2-chloronicotinic acid with an HPLC purity of 99.1% and a yield of 90%. Melting point of the product: 181 ℃ and 182 ℃, MS (m/z): 157(M +), 140, 112, 76, 50.
It will be appreciated by those skilled in the art that modifications and adaptations of the invention may be made in light of the teachings of the present specification.

Claims (10)

  1. The preparation method of 2-chloronicotinic acid is characterized by comprising the following steps:
    1) reacting malondialdehyde with cyanoacetamide in the presence of acid to obtain a product containing 2-hydroxy-3-cyanopyridine;
    2) reacting the product obtained in the step 1) with phosphorus oxychloride in the presence of alkali to generate 2-chloro-3-cyanopyridine;
    3) hydrolyzing the 2-chloro-3-cyanopyridine obtained in the step 2) to obtain the 2-chloronicotinic acid.
  2. 2. The method according to claim 1, wherein the molar ratio of malondialdehyde, cyanoacetamide and acid in step 1) is 1:1-1.2: 0.1-0.5.
  3. 3. The method according to claim 1 or 2, wherein the acid in step 1) is or inorganic acid, preferably or two of acetic acid or propionic acid, and the inorganic acid is hydrochloric acid or sulfuric acid, and the base in step 2) is or more of triethylamine, pyridine or cyclohexylamine.
  4. 4. The method of any of claims 1-3, wherein the step 1) reaction is performed in the presence of a solvent, preferably or more of dichloromethane, ethyl acetate, chloroform.
  5. 5. The method according to claim 4, wherein the step 1) further comprises the steps of: separating an organic phase from a product containing 2-hydroxy-3-cyanopyridine obtained by the reaction in the step 1); drying the organic phase by using anhydrous sodium sulfate, and filtering to obtain filtrate;
    directly feeding the filtrate into the step 2) to be used as a raw material for reacting with the phosphorus oxychloride.
  6. 6. The process according to claim 5, wherein in the step 2), the molar ratio of the 2-hydroxy-3-cyanopyridine to the phosphorus oxychloride to the base is from 0.8:0.9 to 3.0:0.7 to 1.5.
  7. 7. The method according to claim 4, wherein the step 1) further comprises the steps of: separating an organic phase from a product containing 2-hydroxy-3-cyanopyridine obtained by the reaction in the step 1); drying the organic phase by using anhydrous sodium sulfate, and filtering to obtain filtrate;
    evaporating the solvent in the filtrate, and then putting the filtrate into the step 2) to react with the phosphorus oxychloride.
  8. 8. The method according to claim 7, wherein in the step 2), the molar ratio of phosphorus oxychloride to alkali is 1 to 3: 0.8-1.2.
  9. 9. The method according to any one of claims 1 to 8 to , wherein in step 3), the product obtained in step 2) is hydrolyzed under reflux in an aqueous solution of sodium hydroxide.
  10. 10. The preparation method of , according to any one of claims 4-9, wherein in step 1), after dissolving malondialdehyde and cyanoacetamide in a solvent, the acid is added dropwise into the reaction system, the temperature of the reaction system is controlled to be not more than 15 ℃ during the acid addition, and after the acid addition is completed, the temperature is raised to reflux the system for reaction;
    in the step 2), the alkali is dropwise added into a reaction system containing 2-hydroxy-3-cyanopyridine and phosphorus oxychloride, the temperature of the reaction system is controlled to be 0-5 ℃, and after the alkali is dropwise added, the temperature is raised until the system is refluxed for reaction.
CN201810804247.7A 2018-07-20 2018-07-20 New preparation method of 2-chloronicotinic acid Active CN110734398B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810804247.7A CN110734398B (en) 2018-07-20 2018-07-20 New preparation method of 2-chloronicotinic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810804247.7A CN110734398B (en) 2018-07-20 2018-07-20 New preparation method of 2-chloronicotinic acid

Publications (2)

Publication Number Publication Date
CN110734398A true CN110734398A (en) 2020-01-31
CN110734398B CN110734398B (en) 2023-06-02

Family

ID=69234792

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810804247.7A Active CN110734398B (en) 2018-07-20 2018-07-20 New preparation method of 2-chloronicotinic acid

Country Status (1)

Country Link
CN (1) CN110734398B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114181139A (en) * 2021-12-27 2022-03-15 四川仁安药业有限责任公司 Synthetic method of 5-halogenated nicotinic acid

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081451A (en) * 1975-03-20 1978-03-28 Schering Corporation Process for preparing 2-halogeno nicotinic acids
JPH08301847A (en) * 1995-04-28 1996-11-19 Koei Chem Co Ltd Production of 2-chloro-3-substituted pyridine
CN101851193A (en) * 2009-10-20 2010-10-06 西华大学 Preparation method of 4-trifluoromethyl nicotinic acid
CN102675193A (en) * 2011-03-11 2012-09-19 上海科胜药物研发有限公司 Novel synthesis method of Nevirapine key intermediate 2-chloro-3-amino-4-methylpyridine
CN104592104A (en) * 2015-01-13 2015-05-06 江苏中邦制药有限公司 Method for preparing 2-chloronicotinic acid
CN108191749A (en) * 2018-03-29 2018-06-22 上海赫腾精细化工有限公司 A kind of preparation method of flonicamid and its intermediate 4- trifluoromethyl nicotinic acids

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081451A (en) * 1975-03-20 1978-03-28 Schering Corporation Process for preparing 2-halogeno nicotinic acids
JPH08301847A (en) * 1995-04-28 1996-11-19 Koei Chem Co Ltd Production of 2-chloro-3-substituted pyridine
CN101851193A (en) * 2009-10-20 2010-10-06 西华大学 Preparation method of 4-trifluoromethyl nicotinic acid
CN102675193A (en) * 2011-03-11 2012-09-19 上海科胜药物研发有限公司 Novel synthesis method of Nevirapine key intermediate 2-chloro-3-amino-4-methylpyridine
CN104592104A (en) * 2015-01-13 2015-05-06 江苏中邦制药有限公司 Method for preparing 2-chloronicotinic acid
CN108191749A (en) * 2018-03-29 2018-06-22 上海赫腾精细化工有限公司 A kind of preparation method of flonicamid and its intermediate 4- trifluoromethyl nicotinic acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
朱卓越,等: "3-溴-1,6-萘啶-5(6H)-酮的合成", 《华中师范大学学报(自然科学版)》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114181139A (en) * 2021-12-27 2022-03-15 四川仁安药业有限责任公司 Synthetic method of 5-halogenated nicotinic acid
CN114181139B (en) * 2021-12-27 2023-12-08 四川仁安药业有限责任公司 Synthesis method of 5-halogenated nicotinic acid

Also Published As

Publication number Publication date
CN110734398B (en) 2023-06-02

Similar Documents

Publication Publication Date Title
WO2021056811A1 (en) Imine salt derivative and preparation method therefor, and preparation method for nicotine
CN108129288B (en) Synthesis method of trans-3-hydroxycyclobutylformic acid
JP2016504404A (en) Method for producing pyripyropene compound
AU771484B2 (en) Process for the preparation of a pyridinemethanol compound
CN110734398A (en) process for preparing 2-chloronicotinic acid
DK2170829T3 (en) Process for the preparation of a toluidinforbindelse
CN113278021B (en) Preparation method of 1, 7-diazaspiro [3.5] nonane-7-tert-butyl formate and oxalate thereof
CN112645813B (en) Preparation method of (R) -3-cyclohexene carboxylic acid
WO2014206254A1 (en) 4-benzyl-1-phenethyl-piperazine-2,6-dione preparation method, and intermediate and preparation method thereof
CN113861034A (en) Preparation method of 2-fluoro-3-nitrobenzoic acid
CN107721917B (en) Green synthesis method of polysubstituted nicotinate compound
CN104447528B (en) The preparation method of pyridine-2,3-diethyl dicarboxylate
KR20140140398A (en) A synthetic method of high purity mirtazapine
CN114044783B (en) Preparation method of idosiban and intermediate thereof
CN106966912A (en) (R) preparation method of 3 amino butanols
CN110862311B (en) Synthesis method of 1-hydroxycyclopropanecarboxylic acid and carboxylate
CN114539244B (en) Preparation method of moxifloxacin hydrochloride
CN111153853B (en) Preparation method of 2-chloronicotinic acid
CN109456257B (en) Preparation method of high-yield 2-chloro-5-nitropyridine
CN103214462A (en) Preparation method of esomeprazole sodium salt
CN115819339A (en) Synthesis method of 6, 7-difluoro-8-hydroxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid
CN117624097A (en) Preparation method of caronic anhydride
CN111848432A (en) Preparation method of p-aminosalicylic acid
CN117534613A (en) Preparation method of 3-aminopyridine-2-carboxylic acid methyl ester
JPH08816B2 (en) Method for producing 2-butyl-4-chloroimidazole-5-carbaldehyde

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant